High quality products to support Pathologists and Biological and Environmental Scientists

Showing 1–8 of 18 results

Control for SARS-CoV-2 Serologic Assay

$250.00

Mixture of recombinant humanized IgG and IgM monoclonal antibodies directed against the NP protein of SARS-CoV-2 virus. This serves as an excellent and harmless positive control for Anti-SARS-CoV-2 immunoassays.

SARS-CoV-2 Antibody Assay

$450.00

This is an Antibody Serologic Assay (SCSA) for SARS-CoV-2. 

 

This test has not been reviewed by the FDA.

 

The SARS-CoV-2 Antibody rapid test is a lateral flow chromatographic immunoassay for the qualitative detection of IgM/IgG anti-SARS CoV-2 antibody which may be found in samples such as serum, plasma, whole blood or cell culture media. This product is suitable for screening for the presence of SARS-CoV-2 reactive antibody in a Research Use Only Fashion.

Negative results do not rule out SARS-CoV-2 infection, particularly in those who have been in contact with the virus. Follow-up testing with a molecular diagnostic should be considered to rule out infection in these individuals.

Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.

Positive results may be due to past or present infection with non-SARS-CoV-2 coronavirus strains, such as coronavirus HKU1, NL63, OC43, or 229E.

SARS-CoV-2 Antigen Assay (SCAA)

$125.00

25 tests per kit.

Used for in vitro qualitative detection of SARS-CoV-2 antigens in human swabs samples (Nasopharyngeal swab and oropharyngeal swab). It can only be used as a supplementary test indicator for suspected cases with negative PCR test of SARS-CoV-2 or used in conjunction with PCR testing in the diagnosis of suspected cases.

 

COVID-19 Real-Time PCR assay EUA (USA)

$1,321.04

Product Features

  • • FOR US ONLY
  • • Rapid detection and exclusive to the COVID-19 strain
  • • Does not detect other related coronavirus strains
  • • High priming efficiency
  • • Accurate controls to confirm extraction, and assay validity
  • • Lyophilised components for ambient shipping
  • • Highly specific detection profile

This test has been authorized by FDA under an EUA for use by authorized laboratories.

Coronavirus (COVID-19, Strain 2019-nCoV)

$1,321.04

Product Features

  • • Exceptional value for money
  • • Rapid detection of 2019-nCoV
  • • Positive copy number standard curve for quantification
  • • Highly specific detection profile
  • • High priming efficiency
  • • Broad dynamic detection range (>6 logs)
  • • Sensitive to < 100 copies of target
  • • Accurate controls to confirm findings

 

exsig® COVID-19 Direct

$2,103.08

A total workflow solution with all reagents and components provided from start to finish.

  • • Total workflow solution
  • • All reagents and components provided from start to finish
  • • Rapid protocol with fewer handling steps
  • • For use with dry swabs
  • • Viral inactivation; Preparation, Amplification, Diagnosis
  • • Total chemistry optimisation
  • • Low shipping costs with ambient shipping
  • • Includes our genesig® Real-Time PCR Coronavirus COVID-19 (CE IVD)

SNPsig® SARS-CoV-2 (20I/501Y.V1) Identification Kit

$1,500.00
  • • For the detection of the SARS-CoV-2 (20I/501Y.V1 UK)
  • • Rapid detection of specific detection profiles
  • • High priming efficiency
  • • Sensitive to < 100 copies of target
  • • Positive copy number standard curve for quantification
  • • Accurate controls to confirm findings
  • • 96 reactions, includes master mix

SNPsig® SARS-CoV-2 (N501Y) Identification Kit

$1,500.00
  • • For the detection of the SARS-CoV-2 variants with the N501Y mutation (UK, South Africa and Brazil)
  • • Rapid detection of specific detection profiles
  • • High priming efficiency
  • • Sensitive to < 100 copies of target
  • • Positive copy number standard curve for quantification
  • • Accurate controls to confirm findings
  • • 96 reactions, includes master mix
X